Filter
437
Filtered Results: 437
Text search:
International
Union
Agianst
Tuberculosis
and
Lung
Disease,
World
Health
Organization,
CDC,
et.
al
Featured
Recommendations
44
New Publications
95
Language
Document type
No document type
325
Studies & Reports
47
Guidelines
33
Manuals
14
Strategic & Response Plan
6
Fact sheets
5
Training Material
4
Infographics
2
Situation Updates
1
Countries / Regions
Western and Central Europe
21
Global
15
India
15
Eastern Europe
12
Bangladesh
9
Namibia
8
Kenya
6
Latin America and the Carribbean
6
Myanmar / Burma
6
Benin
5
Rwanda
5
Malawi
5
Africa
5
South Africa
5
Uganda
5
Nepal
4
Senegal
4
Cambodia
4
Tanzania
4
Germany
4
Ethiopia
4
Botswana
4
Ukraine
3
Asia
3
South–East Asia Region
3
Ghana
2
Zimbabwe
2
Philippines
2
Mozambique
2
Russia
2
Liberia
2
Tajikistan
1
Colombia
1
El Salvador
1
Lesotho
1
Sierra Leone
1
Gambia
1
Nigeria
1
Afghanistan
1
Armenia
1
Eastern Europe and Central Asia
1
Argentina
1
Vietnam
1
Brazil
1
Sri Lanka
1
Poland
1
Bhutan
1
Zambia
1
South Sudan
1
Indonesia
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
50
TB
43
Studies & Reports
28
Policies
22
Non-communicable Diseases
10
Bacteriology
9
Disease Prevention & Control
9
Pediatrics
7
Capacity Building
6
Demograhic Health Surveys DHS
5
Guidelines
5
Community Health
5
Paediatrics
4
Cancer
3
Countries
3
Drugs & Medical Equipment
3
Statistics
3
Leprosy
3
Global Health
3
Communicable Diseases
2
Child Health
2
COVID-19
2
Community Health
2
Cancer Treatment & Resources
2
Infection Control & Prevention (IPC)
2
Health System Strengthening
2
NCD
2
Palliative Care
2
Gynaecology & Obstetrics
2
HIV & STI
2
Reproductive Health
2
Under-5 nutrition
1
Buruli Ulcer
1
Diabetes
1
Monitoring & Evaluation
1
Palliative Care
1
Other Cancer diseases
1
Pediatric cancer
1
Maternal & Child Health
1
Public Health
1
Training Manuals
1
Medical Devices & Equipment
1
Other
1
Respiratory Infections
1
Surgery & Anaesthesia
1
COPD/Asthma
1
Nutrition
1
Maternal Health
1
Primary Health Care
1
Radiology and Diagnostic
1
Toolboxes
Prevention & Control
27
Detection & Diagnosis
26
Adults
23
Drug resistant TB
23
Training
22
Children
21
TB & Prisoners
20
Childhood TB
12
Advocacy & Communication
11
Disease Prevention & Control
11
Research & Access
11
TB/HIV Coinfection
11
TB & Other Vulnerable Populations
10
Policies & Strategies
8
Eastern Europe & Central Asia
8
General
7
Prevention & Strategies
7
Reports
6
Rwanda
5
TB/HIV Global
5
Clinical Guidelines
5
AmR (Region of Americas)
5
SEAR (South-east Asia Region)
5
TB & Drug Abuse
4
Vaccines & Immunization
4
National Policies
4
Namibia
4
Laboratory
4
Workplace
4
HIV &TB
4
Policies and guidelines
4
Malawi
4
TB
4
Epidemiology
4
Children & Adolescents
3
General
3
Nutrition
3
Uganda
3
HIV and coinfection
3
Western & Central Europe
3
South-east Asia Region
3
Eastern Europe and central Asia
3
Biosafety
2
Treatment & Prevention
2
Clinical Aspects
2
Eastern Mediterranean Region
2
Treatment Guidelines HIV
2
IEC Materials
2
TB
2
SOPs
2
Mozambique
2
Laboratory
2
Georgia
2
Medical professionals
2
Sustainable Development Goals
2
Ethiopia
2
International
2
Clinical Guidelines
2
Global Impact: Socio-economic, health services, TB & HIV
2
Medical & Community Masks
2
TB/HIV
2
Environment
2
Clinical Aspects & Diagnostics
2
Overview, Studies & Reports
2
General Information & Methodology
2
Clinical Aspects & Diagnosis
2
Studies & Reports
2
Ghana
2
Tuberculosis
2
Prevention of Disabilites
2
Tobacco
2
Kenya
2
Universal Health Coverage & Primary Health Care
2
Reports & Studies
2
Moldova
1
Training
1
Ebola Prevention & Control
1
Surveillance
1
Clinical Aspects, Treatment & Prevention
1
Europe
1
Preparedness, Response & Risk Communication
1
Studies & Reports
1
Natural Disasters
1
Ukraine
1
WPRO (Western Pacific Region)
1
Public Health
1
Training Manuals
1
Eastern Europe
1
Prophylaxis
1
African Region
1
Ebola
1
Advocacy
1
Country Guidelines
1
Training
1
Belarus
1
Key Resources
1
Communication & Training
1
Climate & Health
1
Health Personnel
1
Infection Control General
1
For General Public & Community
1
Appeals and Response Plans
1
Situation Reports COVID-19
1
Preparedness, Response & Risk Communication
1
TB/COVID-19
1
Others
1
Health Promotion
1
Community Health Workers CHW
1
Online Resources
1
Colombia
1
Brazil
1
Planetary Health
1
Advocacy
1
Clean air
1
Essential Medicines
1
Prices and Patents
1
Falsified & Substandard
1
Model Formulary
1
Pharmacy Practice
1
Traditional & Herbal Medicines
1
Guiding documents and principles
1
Argentina
1
Guidelines & Manuals
1
Antimicrobial Resistance (AMR)
1
Education Principles
1
Health Impact & Climate Change
1
NTDs General
1
General Information
1
Air Pollution
1
Armenia
1
Children's Rights
1
War Surgery & Wound Care
1
Botswana
1
Liberia
1
Neurological Disorders
1
Community Worker
1
Prophylactic Treatment
1
Albania
1
Germany
1
Lesotho
1
Understanding Global Health
1
International
1
Nigeria
1
Tajikistan
1
Overview & Statistics
1
Community-based Mental Health Care
1
MHPSS Guidelines
1
Antiretroviral Treatment ART
1
Planetary Health
1
Lobby and Advocacy
1
Planetary Health
1
HIV in Key Populations
1
Global Health Financing
1
Prisoners
1
Neurological disorders, Others
1
Preparedness & Prevention
1
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...
30 October 2017
Chapter 8, Prison and Health, published
Experience of national TB partnerships
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...
2nd edition.
Like the original, this second edition of the guidance aims to inform the revision of existing national guidelines and standards for managing Tuberculosis (TB), many of which include guidance on children. It includes recommendations, based on the best available evidence, for improving ...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
The strategic priorities of the CCS 2014–2018 are:
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
Laboratory diagnosis of Buruli ulcer
recommended
A manual for health care providers.
This manual provides expert guidance on the laboratory techniques and procedures used in the diagnosis of Buruli ulcer, a disease caused by Mycobacterium ulcerans. Aimed at laboratory technicians and scientists working on this disease, the manual details the exac...
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. The implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is refer...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma...
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
